Suppression of Conjunctival Scarring by Chymase Inhibitor in a Canine Symblepharon Model
Journal Title: International Journal of Ophthalmology & Eye Science (IJOES) - Year 2016, Vol 0, Issue 6
Abstract
Purpose: To investigate the suppressive effects of a chymase inhibitor (CI) on conjunctival scarring in a canine model of symblepharon induced by alkali burns. Methods: Symblepharon models were made in beagle eyes. A cotton pad soaked in 1 N sodium hydroxide (NaOH) was placed in the conjunctival sac of each eye for 90 seconds, followed by washing the sac with 100 ml of physiological saline. Immediately post treatment, one eye drop (50 μl) including 1 mM-CI or the vehicle (CI-treated group and vehicle-treated group, respectively) was instilled in 5 eyes of 5 beagles once daily for 5 weeks. Fellow eyes were left untreated and served as the normal group. The severity of symblepharon was graded by macroscopic observation. After the eyes were enucleated, conjunctival and scleral tissue specimens were histologically evaluated. Results: Macroscopic observation revealed that symblepharon was induced in all NaOH-treated eyes, while symblepharon scores were significantly lower in the CI group than in the vehicle-treated group. Histological observation indicated a significant reduction in the adhered area in the CI-treated group compared to the vehicle-treated group. Immunohistochemical analysis demonstrated that vimentin-, α-smooth muscle actin-, chymase-, and angiotensin II-positive cells as well as mast cells increased in the vehicle-treated group compared to the normal group, whereas they were reduced in the CI-treated group. Conclusions: Our macroscopic and histological findings indicated that a multiple application of CI eye drops suppressed conjunctival scarring in a canine symblepharon model, suggesting that the topical application of CI may be a promising therapy for symblepharon.
Authors and Affiliations
Tetsuya Sugiyama
Keywords
Related Articles
- EP ID EP200098
- DOI 10.19070/2332-290X-SI07002
- Views 70
- Downloads 0
Real Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration: A Subgroup Analysis of Pooled Retrospective RE-ENACT Study
Background: This subgroup analysis of RE-ENACT study (retrospective, multicenter, observational pooled study on wet age-related macular degeneration [wet AMD], diabetic macular edema, and retinal vein occlusion) evaluate...
Health Coaching and Glaucoma: A Qualitative Evaluation of the Patient Experience in a Preliminary Study
Introduction: Successful medical treatment of glaucoma requires adherence to daily eye drop medications. Health coaching, which has been used successfully for other chronic diseases, may be helpful for glaucoma patients....
Comparative Study Of Visual Outcomes Following Corrective Vitrectomy: Non-Traumatic Versus Traumatic Etiologies
Introduction: Nucleus drop is a rare and serious complication. We investigated visual outcomes following corrective surgery, and compared outcomes between surgeries that followed traumatic injuries and those where the et...
Cataract How Important Is Age of Intervention?
Purpose: To study effect of age of intervention on visual outcome following treatment of pediatric patients with cataract. Setting: Tertiary eye care centre in Dahod at the trijunction of Gujarat, Madhya Pradesh, and Raj...
Influence of Screen Exposure on Vergence Components from Childhood to Adolescence
The goal of our study is to explore the impact of screen exposure on vergence components in children. Sixty-eight healthy children (aged from 5.4 to 16 years old) were studied. We recorded vergence components (near point...